As mediators of innate immunity, neutrophils respond to chemoattractants by adopting a highly polarized morphology. Efficient chemotaxis requires the formation of one prominent pseudopod at the cell front characterized by actin polymerization, while local inhibition suppresses the formation of rear and lateral protrusions. This asymmetric control of signaling pathways is required for directional migration along a chemotactic gradient. Here, we identify the MAGUK protein p55/MPP1 as a mediator of the frontness signal required for neutrophil polarization. We developed a p55 knockout (p55 ؊/؊ ) mouse model, and demonstrate that p55 ؊/؊ neutrophils form multiple transient pseudopods upon chemotactic stimulation, and do not migrate efficiently in vitro. Upon agonist stimulation, p55 is rapidly recruited to the leading edge of neutrophils in mice and humans. Total F-actin polymerization, along with Rac1 and RhoA activation, appear to be normal in p55 ؊/؊ neutrophils. Importantly, phosphorylation of Akt is significantly decreased in p55 ؊/؊ neutrophils upon chemotactic stimulation. The activity of immunoprecipitated phosphatidylinositol 3-kinase ␥ (PI3K␥), responsible for chemoattractantinduced synthesis of PIP3 and Akt phosphorylation, is unperturbed in p55 ؊/؊ neutrophils. Although the total amount of PIP3 is normal in p55 ؊/؊ neutrophils, PIP3 is diffusely localized and forms punctate aggregates in activated p55 ؊/؊ neutrophils, as compared to its accumulation at the leading edge membrane in the wild type neutrophils. Together, these results show that p55 is required for neutrophil polarization by regulating Akt phosphorylation through a mechanism that is independent of PI3K␥ activity.
I
n response to chemotactic stimuli, neutrophils adopt a highly polarized morphology that coordinates their directed cell migration toward sites of injury and inflammation (1) . Neutrophil polarity is characterized by an asymmetric distribution of signals to distinct intracellular locations, a process critical for directional sensing and chemotaxis (2) . Polarity requires directional sensing of external cues by cell surface receptors, triggering a reorganization of the cortical cytoskeleton. At the leading edge of neutrophils, the process is regulated by receptor-mediated activation of G i , which results in activation of the small GTPase, Rac, and accumulation of the membrane signaling lipid, phosphatidylinositol-3,4,5-triphosphate (PIP 3 ). PIP 3 , Rac, and F-actin together participate in a positive-feedback loop that leads to the formation of a single robust pseudopod, even when cells are exposed to a uniform concentration of formyl-Met-Leu-Phe, fMLP (3) (4) (5) (6) . Neutrophils treated with selective inhibitors of PI3K␥ respond to fMLP by forming multiple transient pseudopods laterally, as well as at the leading edge rather than a single persistent pseudopod at the leading edge (3) . These neutrophils exhibit quantitatively normal amounts of F-actin, further supporting the hypothesis that PIP 3 acts to amplify the signal locally, thus confining Rac activation and F-actin polymerization to a distinct region (4) (5) (6) .
The G protein-dependent class I B PI3K, p110␥, is the isoform responsible for the chemoattractant-induced PIP 3 production in neutrophils (7, 8) . Stimulation of neutrophils with fMLP enhances the activity of I B PI3K, p110␥ but not the class I A subunits p85/p110 in immunoprecipitates (7) . Neutrophils treated with the PI3K␥ inhibitors PIK-90 or -93, which inhibit the production of PIP 3 , respond to chemoattractants by forming multiple pseudopods, whereas neutrophils treated with the class I A PI3K inhibitors polarize normally (3) . Furthermore, neutrophils from p110␥ knockout mice exhibit both defective chemotaxis in vitro and reduced accumulation in the peritoneal cavity in response to inflammatory stimuli in vivo (8) (9) (10) (11) . This evidence indicates that stimulation of PI3K␥ causes a rapid increase in the accumulation of PIP 3 , which in turn drives pseudopod formation, thus maintaining neutrophil polarity. However, a major challenge is the identification of the components that regulate localized accumulation of PIP 3 at the leading edge of activated cells.
P55, also called the Membrane Palmitoylated Protein 1 (MPP1), is a prototypical member of a family of signaling proteins termed MAGUKs (membrane associated guanylate kinase homologues). MAGUKs share a number of protein domains including the PDZ domain, a single src-homology-3 (SH3) motif, and a domain homologous to guanylate kinases (GUK) (12, 13) . P55 was originally identified as a scaffolding protein in erythrocytes stabilizing the actin cytoskeleton to the plasma membrane by forming a tripartite complex with protein 4.1R and glycophorin C (14, 15) . Although p55 is ubiquitously expressed, its function in nonerythroid cells remains poorly understood. The p55 gene is composed of 12 exons spanning approximately 28 kb in the q28 region of the human X chromosome (16) . The murine homologue of p55 is located in the syntenic region of the mouse X chromosome (17) . Using conventional gene targeting and deletion techniques, we generated a mouse model systemically lacking p55. Here, we present evidence that p55 regulates neutrophil polarity, and functions as a positive upstream effector of Akt phosphorylation. These unexpected findings unveil a role for p55 in neutrophil polarity with functional implications for both autoinflammatory diseases and infections.
Results
Targeted Deletion of Mouse MPP1 Gene. Erythrocyte p55/MPP1 is the founding member of a subgroup of MAGUKs (12, 13) . The p55-like MAGUKs currently include seven members in the human genome, and each member is characterized by the presence of PDZ, SH3, and GUK domains (Fig. 1A) . In addition to these three core domains, some p55-like MAGUKs also contain the L7B domain in the N terminus, the D5 domain that binds to cytoskeletal protein 4.1, a tyrosine phosphorylation (TP) motif, and a very C-terminal sequence of unknown function (12, 18) . Although detailed biochemical characterization of several p55-like MAGUKs has been performed, the in vivo function of these proteins remains unknown as no mouse models of the gene deficiency have been reported for any of the seven members. Using standard gene targeting approaches, we systemically deleted the C-terminal half of p55 that includes exons 7-11 ( Fig. 1 B-E) . This finding was confirmed at the protein level by Western blotting of erythrocytes where p55 is abundantly expressed (Fig. 1E) . We used several antibodies generated against p55 to firmly establish the protein null phenotype: (a) Rabbit polyclonal antibody against native erythrocyte p55; (b) Rabbit polyclonal antibody against the Nterminal peptide, PEMP1 (EVRKVRLIQFEKVTEE); (c) Rabbit polyclonal antibody against the D5 domain peptide (EAPSCSPFGKKKKYK); and (d) Mouse monoclonal antibody raised against the GUK domain of p55. Affinity-purified antibodies failed to detect any trace of the full length as well as the N-terminal truncated peptide of p55 in erythrocytes and other tissues confirming the generation of p55 null mouse model (Fig. S1 ).
Phenotype Characterization of p55 ؊/؊ Mice. The p55 Ϫ/Ϫ mice were born at normal Mendelian ratios but their litter size was consistently small (3-5 pups). Initial pathology report indicated that the liver, heart, kidney, adrenal gland, spleen, pancreas, lung, cerebrum, cerebellum, and medulla oblongata of p55 Ϫ/Ϫ mice were within normal limits. Initial analysis of peripheral blood obtained from three adult animals indicated no major differences in hematologic indices including white blood cell number. The morphology of erythrocytes from p55 Ϫ/Ϫ mice appears to be normal; however, detailed analysis will be required to assess the role of p55 in the linkage of protein 4.1R with glycophorin C. Some of these studies are currently underway in our laboratory.
The MPP1 gene located on human Xq28 was originally mapped within a CpG island 30 kb centromeric to the factor factor VIII gene (19) . Both MPP1 and factor VIII genes are transcribed in the same orientation from telomere to centromere (20) . Interestingly, the gene for X-linked dyskerotosis congenita (dyskerin/DKC) lies tail to tail with MPP1 gene on Xq28 (20) . Patients with dyskeratosis congenita display increased susceptibility to cancer particularly affecting the progenitors in the skin and bone marrow (21) . Due to the close proximity of MPP1 and DKC genes, we examined whether our deletion of the MPP1 gene may have affected the expression of the DKC gene. Polyclonal antibodies against the N-terminal (residues 74-88) and the C-terminal (residues 382-396) peptides of mouse dyskerin did not show any alteration of dyskerin protein expression in the p55 Ϫ/Ϫ tissues. In addition, we examined p55 expression in the erythrocytes of a hypomorphic Dkc1 mutant mouse model that recapitulates some features of human dyskeratosis congenita (22) . Again, no difference in the level of p55 was observed by Western blotting. These observations suggest that the expression of DKC gene is not affected in the p55 Ϫ/Ϫ mice. However, we cannot rule out the possibility that the absence of p55 may affect specific functions of dyskerin protein in some tissues. During our previous studies on the characterization of erythrocyte p55, we developed a highly specific monoclonal antibody directed against the GUK domain (23). This antibody detected robust expression of p55 in both human and mouse neutrophils (Fig. S1 ). The serendipitous finding led us to investigate the role of p55 in mouse neutrophils. First, the morphology of bone marrow neutrophils was visualized upon plating onto fibronectin-coated coverslips. Neutrophils were stimulated with a uniform concentration of 100 nM fMLP for 5 min, fixed, permeabilized, and stained for F-actin. Neutrophils lacking p55 respond to fMLP by forming multiple lateral pseudopods instead of the single clearly-defined leading or trailing edge pseudopod as observed in WT neutrophils ( Fig. 2 A and B) . Greater than 60% of p55 Ϫ/Ϫ neutrophils extended more than one pseudopod (Fig. 2C ). To further quantify the loss of polarity, WT and p55 Ϫ/Ϫ neutrophils were immunostained for ␤-tubulin and the percentage of cells with a rear orientation of the microtubule network were counted (Fig. 2D) . Roughly 80% of WT neutrophils orient their microtubules toward the back of the cell upon stimulation compared to only approximately 11% of p55 Ϫ/Ϫ neutrophils. The loss of polarity in p55 Ϫ/Ϫ neutrophils predicted a defect in cell migration in response to chemoattractants. To test this hypothesis, in vitro transwell assays were performed. Loss of p55 expression resulted in a reduced number of neutrophils migrating through the filter into the lower chamber of a transwell device, especially at higher concentrations of fMLP (Fig. 2E) . Furthermore, time-lapse video microscopy showed that p55 Ϫ/Ϫ neutrophils eventually migrate toward a micropipette point-source of chemoattractant, but take circuitous routes to reach it (Movies S1 and S2). This abnormal migratory behavior appears to be a direct consequence of defective polarization and the inability of p55 Ϫ/Ϫ neutrophils to form a single leading edge pseudopod that orients itself toward the chemotactic gradient. Using a specific monoclonal antibody against p55, we established the presence of p55 in human neutrophils by Western blotting (Fig.  S1 A) . Next, p55 was localized in both resting and stimulated human neutrophils by immunofluorescence microscopy. In resting neutrophils, p55 is uniformly distributed around the cell periphery (Fig.  S1B ). Upon treatment with chemoattractant, the majority of p55 translocated to the leading edge and co-localized with the F-actin (Fig. S1B ). This observation suggests that p55, like other MAGUKs, may be involved in the trafficking of critical membrane components, and participates in the formation of protein complexes at the neutrophil leading edge. Biochemical analysis was performed on WT and p55 Ϫ/Ϫ neutrophils to investigate the activation of well-known regulators of the polarization pathway. Total F-actin polymerization was quantified in neutrophils by incubating cells with FITC-Phalloidin and analyzing relative fluorescence by flow cytometry. There was no significant difference in the total amount of F-actin polymerization between WT and p55 Ϫ/Ϫ neutrophils after stimulation with fMLP at various time points (Fig. 3B ). This observation is consistent with the immunofluorescence images showing the presence of F-actin staining in the multiple pseudopod extensions of p55 Ϫ/Ϫ neutrophils (Fig. 2 A) . Next, we investigated the activation of the small GTPases, Rac1 and RhoA, which function as critical components of neutrophil gradient sensing and polarization (3, 4) . Using a well-established GST-PBD based pull-down assay (24) , the total amount of active Rac1 was measured in WT and p55 Ϫ/Ϫ neutrophils stimulated with fMLP. There was no significant difference in Rac1 activation (Fig.  3A) . To measure active RhoA, a more sensitive chemiluminescence-based G-LISA was used. Again, the activation of RhoA was comparable between WT and p55 Ϫ/Ϫ neutrophils (Fig. 3C) . neutrophils treated with specific inhibitors of PI3K␥ (3). Therefore, we examined the phosphorylation of Akt as a downstream indicator of PI3K activity and/or PIP 3 accumulation in p55 Ϫ/Ϫ neutrophils (Fig. 3D ). WT and p55 Ϫ/Ϫ neutrophils were stimulated with fMLP, and lysates were analyzed by Western blotting using a polyclonal antibody that specifically recognizes Akt that is phosphorylated at threonine 308 (pAKT T308 ). In WT neutrophils, there was an immediate phosphorylation of Akt that peaked at 1 min and gradually decreased by approximately 50% within 5 min (Fig. 3D ). This phosphorylation of Akt corresponds to rapid activation of PI3K␥ and the production and accumulation of PIP 3 . In contrast, Akt phosphorylation was significantly reduced in p55 Ϫ/Ϫ neutrophils at each time point after fMLP stimulation (Fig. 3D) . The total amount of Akt protein was comparable between WT and p55 Ϫ/Ϫ neutrophils in four independent experiments. These results suggest that p55 mediates cell polarity by regulating the PI3K␥-PIP 3 pathway that is critical for the stability and maintenance of the leading edge pseudopod in neutrophils.
Status of PI3K␥ Activity in p55 ؊/؊ Neutrophils. Neutrophils lacking PI3K␥ show reduced Akt phosphorylation after fMLP stimulation as compared to WT neutrophils (8) . Furthermore, neutrophils treated with the PI3K␥ inhibitors show multiple lateral pseudopods upon stimulation (3), a feature that is similar to activated p55 Ϫ/Ϫ neutrophils (Fig. 2 A) . Therefore, we examined whether the reduced Akt phosphorylation in p55 Ϫ/Ϫ neutrophils resulted from alterations of PI3K␥. PI3K␥ was immunoprecipitated from WT and p55 Ϫ/Ϫ neutrophils and its lipid kinase activity was measured (Fig.  3E) . Immunoprecipitated PI3K␥ was incubated with phosphatidylinositol and [ 32 ]ATP, the lipid products were separated by thin layer chromatography, and the formation of radiolabeled phosphatidylinositol 3-phosphate, PI(3)P, was observed (Fig. 3F) . The production of PI(3)P, which reflects the enzymatic activity of PI3K␥, was similar in WT and p55 Ϫ/Ϫ neutrophils (Fig. 3E) . These results suggest that p55 does not directly affect the activity of PI3K␥, but may be involved in the localization of either PI3K␥ or PIP 3 .
Alternatively, p55 may participate in a signaling pathway that regulates Akt phosphorylation in neutrophils in a previously unrecognized manner. Fig. S1E shows a comprehensive Western blot of the canonical signaling components of the PI3K-Akt pathway. In p55 Ϫ/Ϫ neutrophils, only the phosphorylation of Akt (at both T308 and S473) is affected.
Status of PIP3 in p55 ؊/؊ Neutrophils. Our current hypothesis is that p55 regulates PIP 3 localization at specific membrane sites of polarized neutrophils. To analyze PIP 3 we used a monoclonal anti-PIP 3 antibody (Invitrogen). To validate the specificity of this antibody, we measured the PIP 3 immunofluorescence signal in neutrophils treated with the PI3K␥ inhibitor PIK-90, and observed a significant reduction in PIP 3 staining (shown in Fig. S1G ). In resting WT and p55 Ϫ/Ϫ neutrophils, PIP 3 staining was uniformly localized around the cell periphery (Fig. 4A) . Upon activation of WT neutrophils, PIP 3 translocates to the leading edge as defined by F-actin staining. In activated p55 Ϫ/Ϫ neutrophils PIP 3 does not consolidate to one region, but rather forms punctate aggregates at various sites of F-actin polymerization (Fig. 4A) . In addition, we measured total PIP 3 content in the resting and activated WT and p55 Ϫ/Ϫ neutrophils (fixed and permeabilized) using the anti-PIP 3 monoclonal antibody and TRITC-conjugated anti-mouse IgM. The PIP 3 content was measured by measuring the relative fluorescence intensity by flow cytometry (Fig. 4B) . No significant difference was observed in the total PIP 3 content of WT and p55 Ϫ/Ϫ neutrophils at four different time points of activation, corresponding to the data shown in the PI3K␥ assay (Fig. 3E) . Thus, the production of PIP 3 is not altered under these conditions. Since PIP 3 is diffusely localized in activated p55 Ϫ/Ϫ neutrophils, our results suggest that p55 may regulate PIP 3 trafficking or its tethering to the leading edge plasma membrane. In the absence of p55, PIP 3 is still produced at quantitatively normal levels, but forms punctate aggregates throughout activated p55 Ϫ/Ϫ neutrophils, thus inhibiting Akt phosphorylation at specific membrane sites. Time Time 
Discussion
The original cloning and characterization of p55/MPP1 as a heavily palmitoylated peripheral membrane protein in human erythrocytes led to its current designation as one of the founding members of the MAGUK family of scaffolding proteins (13, 18) . In mature erythrocytes, p55 forms a ternary complex with protein 4.1R and glycophorin C with implications in the regulation of cell shape and membrane stability (25) . MAGUKs, including the Drosophila Dlg tumor suppressor, function as regulators of cell polarity (26) . Recent findings have shown that p55 forms a complex with whirlin and regulates cell polarity during hair cell development (27) . Mutations in the whirlin gene cause deafness and Usher syndrome, and p55 also interacts with MPP5 to link the Usher protein network with the Crumbs protein complex in the retina (28) . These observations suggest a role for p55 in the regulation of the apico-basal Crumbs polarity complex and actin polymerization in both ear and retina. Despite this improved biochemical understanding, the biological function of p55 remains unexplored as no animal models of p55 deficiency exist.
In this manuscript, we report the generation and characterization of a mouse model with systemic p55 null phenotype. The p55 knockout model provides evidence for the essential role of p55 in neutrophil polarity. In contrast to WT neutrophils, which polarize to form a defined leading and trailing edge upon stimulation with chemoattractants, the p55 Ϫ/Ϫ neutrophils form multiple pseudopods in all directions ( Fig. 2 A and B) . Consequently, they lack a prominent leading edge resulting in impaired chemotaxis (Fig. 2E) . Because p55 Ϫ/Ϫ neutrophils extend pseudopods in random directions, they fail to chemotax efficiently. Time-lapse video microscopy shows that p55 Ϫ/Ϫ neutrophils eventually reach a pipette tip dispensing chemoattractant, but take circuitous paths in achieving their final destination (Movies S1 and S2). Neutrophils are the first responders to infection; and thus their delayed migration could compromise the effectiveness of the immune response. A detailed future study will determine the precise in vivo function of p55 in inflammation and infections using a large number of age-matched p55 Ϫ/Ϫ mice with different genetic backgrounds.
To investigate the biochemical basis of p55 function in neutrophil polarity, we examined its role in the reorganization of the actin cytoskeleton in lieu of its known interactions with protein 4.1R at the actin-spectrin junction in the erythrocyte membrane (14) . Moreover, it is well established that the regulation of F-actin polymerization by small Rho GTPases serves as a critical determinant of the frontness signal in neutrophils (1) . Despite the colocalization of p55 with F-actin at the front end of activated WT neutrophils (Fig. S1 A) , polymerization of F-actin and activation of Rac1 and RhoA appear to be unaltered in p55 Ϫ/Ϫ neutrophils (Fig.  3) . This finding was not surprising as p55 Ϫ/Ϫ neutrophils are still able to assemble and extend pseudopods, albeit in random directions. The formation of multiple protrusions in p55 Ϫ/Ϫ neutrophils suggests that their polarity defect originates either from the defective stabilization of the leading edge pseudopod and/or the inability to inhibit the formation of pseudopods elsewhere. It appears that this spatial separation of polarity signals is compromised in p55 Ϫ/Ϫ neutrophils.
Using the p55 Ϫ/Ϫ model, we provide evidence that p55 regulates a signaling pathway that lies upstream of Akt phosphorylation in neutrophils. In WT neutrophils, Akt phosphorylation occurs within 10 s following agonist stimulation peaking at around 1 min. Upon stimulation with fMLP, the p55 Ϫ/Ϫ neutrophils show a marked decrease in Akt phosphorylation at all time points (Fig. 3D) . This observation suggests that p55 either directly regulates neutrophil PI3K␥ activity or indirectly influences PIP 3 -dependent processes that are upstream regulators of Akt phosphorylation.
The morphology of p55 Ϫ/Ϫ neutrophils resembles human neutrophils treated with specific inhibitors of PI3K␥ (3). To investigate the possibility that p55 may regulate PI3K␥ activity, we immunoprecipitated PI3K␥ and measured its activity (Fig. 3 E and F) . PI3K␥ activity was comparable between the WT and p55 Ϫ/Ϫ neutrophils, suggesting that p55 functions either downstream of PI3K␥ or regulates Akt phosphorylation through an alternative pathway. To examine this issue further, we measured total PIP 3 produced in the neutrophils after chemotactic stimulation. No difference was observed in the amount of PIP 3 in WT and p55 Ϫ/Ϫ neutrophils, a feature consistent with the PI3K␥ activity assay. In resting WT and p55 Ϫ/Ϫ neutrophils, the PIP 3 staining is uniformly localized around the cell periphery (Fig. 4A) . Upon activation of WT neutrophils, the PIP 3 translocated and accumulated at the leading edge as defined by F-actin staining. Interestingly, the PIP 3 is diffusely localized and forms punctate aggregates in activated p55 Ϫ/Ϫ neutrophils (Fig. 4A) . PIP 3 appears to aggregate at sites of F-actin polymerization, where the cell may be trying to form pseudopods. Since PIP 3 consolidation at the leading edge is essential during polarization, we surmise that the punctate localization of PIP 3 in activated p55
Ϫ/Ϫ neutrophils contributes to the morphologic instability of these cells (Fig. 5) . Future studies will determine if p55 can directly interact with or influence PIP 3 trafficking and localization.
In summary, we identified a role of p55, a major palmitoylated erythrocyte membrane protein, in the regulation of neutrophil polarity. This finding lends further credence to the emerging paradigm that MAGUKs function as critical regulators of cell polarity. The p55 null mouse model will help to expedite the elucidation of the precise mechanism of p55-dependent signaling pathways that amplify the cellular polarization process in neutrophils and in many other cells. Whether the known Xq28-linked immune deficiency disorders and myeloid abnormalities are influenced by p55/MPP1 will now be testable in the near future. In p55 Ϫ/Ϫ neutrophils, chemoattractants induce the extension of multiple pseudpods in various directions. PIP 3 aggregates in various locations coinciding with F-actin polymerization, rather than accumulating at one leading edge. PIP 3 has emerged as a critical mediator of pseudopod stability during neutrophil polarization. Because total PIP 3 production is unchanged in the absence of p55, we hypothesize that the polarity and Akt-phosphorylation defects are due to abnormal trafficking or accumulation of PIP 3 at the front of the cell.
Materials and Methods

Construction
(Genome Systems) (29) . P1 clone #3975, determined to contain the murine p55 gene by dot blot analysis, was EcoRI digested and shotgun subcloned into the vector pGEM-4Z. A 3.5 kb EcoRI fragment containing exon 6 and flanking introns was subcloned into the EcoRI site of the targeting plasmid pPGK, upstream of the neomycin (neo) cassette. A 8 kb EcoRI fragment containing exon 12 and flanking introns was subcloned into a modified pCR2.1 vector (Invitrogen) allowing the excision of this fragment using the enzymes NotI and SacII. The 8 kb arm was then subcloned into a NotI-SacII site downstream of the neo cassette. The final targeting construct resulted in the deletion of a 6.5 kb EcoRI fragment containing exons 7-11 and the insertion of a neo cassette. Exons 7-11 encode the protein 4.1-binding domain (D5) and the guanylate kinase-like (GUK) domain of p55 (Fig. 1D) .
Embryonic Stem Cell Transfection and Blastocyst Injection. The targeting construct (Ϸ50 g) was linearized at the unique SacII site and electroporated into the R1 embryonic stem (ES) cell line using standard techniques (30) . The G418-resistant clones were screened for homologous recombination by PCR analysis. Primers derived from the exon 5 and the neo cassette (including a nested pair), were used to amplify a junction fragment (Ϸ4 kb) from the correctly targeted allele. A single ES clone (2H7), positive by PCR analysis, was expanded for blastocyst injection and genomic DNA isolation. NcoI-digested genomic DNAs from 2H7, 2H11, and C129/Sv were hybridized to an external 2.5-kb probe that spanned exons 4 and 5, to confirm correct homologous recombination. Mutant allele is distinguished by the presence of a 9 kb band, while the wild-type allele is identified as a 10 kb band. A single band is detected in the 2H7 lane due to the fact that R1 ES cells are derived from male embryos and thus have only one X chromosome. To generate p55 null mice, 2H7-ES cells were injected into C57BL/6J blastocysts followed by implantation into pseudo pregnant mice. The resulting male chimeras were bred with C57BL/6J females to produce hemizygous males (Ϫ/), and heterozygous females (ϩ/Ϫ), which were subsequently mated to generate homozygous females (Ϫ/Ϫ). A combination of Southern blotting and PCR analysis was used for genotyping of mice. The antibodies used in Western analysis included a monoclonal antibody raised against the GUK domain of p55 and an affinity-purified antibody generated against an N-terminal peptide sequence encoded by exon 2 of p55.
Mice. p55 Ϫ/Ϫ mice were back-crossed against C57BL/6J mice for six generations before being used for experiments. Mice were housed in a barrier facility located in the Biological Resources Laboratory at the University of Illinois College of Medicine, Chicago, and all experiments were performed in accordance with the guidelines of the Animal Care Committee.
Isolation of Mouse Neutrophils. Bone marrow (BM) cells were isolated from femurs and tibias of adult mice and layered onto a NycoPrep (Axis-Shield)/72% Percoll (Sigma) gradient. After centrifugation for 30 min at 2,600 rpm, cells at the interface were collected into HBSS filled tubes and washed. Eighty-five to ninety percent of the cells are mature neutrophils as determined by Wright Giemsa staining and Gr-1 ϩ FACS analysis. Human primary neutrophils were isolated from the whole blood of healthy donors by discontinuous 55/72% Percoll gradient centrifugation. For human cells, approximately 95% of those collected at the interface are mature neutrophils.
Chemotaxis Assay. Mouse BM neutrophils (4 ϫ 10 5 ) in warm RPMI were added to the upper chamber of a 3-m pore size filter (BD Biosciences) inserted into a 24-well plate. The lower chambers were filled with varying concentrations of fMLP in RPMI, and the plate was incubated for 30 min at 37°C. After incubation, the filters were removed and the medium in the lower chamber was collected. Cell counts were obtained from a hemacytometer.
GTPase Pull-Down Assays. Assays to measure active Rac1 were carried out as described previously (24) . Briefly, a GST fusion protein of the p21-binding domain of PAK (PBD) was expressed in bacteria and coupled to glutathione-Sepharose beads. The GST-PBD-coupled beads were added to neutrophil lysates and incubated for 45 min at 4°C. Beads were washed three times with 1ϫ lysis buffer and boiled in Laemmli sample buffer. SDS/PAGE and Western blotting were performed as described above, using a monoclonal anti-Rac1 antibody (BD Biosciences). To measure RhoA activity, lysates were analyzed using a RhoA G-LISA kit according to the manufacturer's instructions (Cytoskeleton Inc). 
Antibodies and Reagents
